Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04498117
Title Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5)
Acronym FLORA-5
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors OncoQuest Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | HUN | ESP | CZE | CAN | BRA | BEL | ARG


No variant requirements are available.